SEC Form 4 · accession 0001136261-15-000009
Oruka Therapeutics, Inc. · ORKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
riley mccormack
10% Owner
Period of report
Jan 5, 2015
Accepted (ET)
Jan 7, 2015 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000907654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jan 5, 2015 | S | 150,000 | $0.97 | D | 2,850,000 | I | By Self as trustee for Riley McCormack 2011 Rev Trust |
| COMMON STOCK | Jan 6, 2015 | S | 200,000 | $0.92 | D | 2,650,000 | I | See above |
| COMMON STOCK | Jan 7, 2015 | S | 200,000 | $0.87 | D | 2,450,000 | I | See above |
Table II — derivative securities
No Table II lines on this filing.